Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Value Peer-spectives
Filter by Topic
ASCO’s Value Framework
Commentary
Employers’ Perspective
Letter to our Readers
Oncologist–Patient Communication
Patient Communication
Patient Perspective
Payer’s Perspective
Practice Management
Testimonials
The Patient Perspective
Value in Oncology
Value Propositions
VBCC Perspectives
First Phase of ASCO’s Data-Sharing Standards Completed, Connecting Oncologists during Patient Care
Value Propositions
,
Value Peer-spectives
September 2013, Vol 4, No 7
The completion of the Breast Cancer Treatment Plan and Summary Standard and Implementation Guide, the first phase in a set of interoperability standards, was announced at the 2013 annual meeting of the American Society of Clinical Oncology (ASCO).
Read Article
North Carolina Cuts Hospital Readmissions by 20%
Value Propositions
,
Value Peer-spectives
September 2013, Vol 4, No 7
Hospital readmissions for chronic diseases, including cancer, are associated with a significant and often preventable financial burden in the United States.
Read Article
How Will We Pay for Cancer Care in 2018?
By
Craig Deligdish, MD
From the Editor
,
Value Peer-spectives
September 2013, Vol 4, No 7
Just this month, the Institute of Medicine (IOM) published a report titled “Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis.”
1
This consensus report convened a committee of experts to examine the quality of cancer care in the United States and formulate recommendations for its improvement.
Read Article
Consolidation in Cancer Care Delivery System: The Impact on Quality and Cost
By
Craig Deligdish, MD
From the Editor
,
Value Peer-spectives
July 2013, Vol 4, No 6
The past several years have seen significant consolidation in the healthcare industry. The cost of healthcare in the United States is currently estimated to be 18% of the gross domestic product (GDP), and the costs are projected to increase disproportionately to the GDP during the next decade.
Read Article
Researchers Discover a Set of Proteins that Cause Many Cancer-Related Mutations
Value Propositions
,
Value Peer-spectives
July 2013, Vol 4, No 6
A new study led by researchers at the National Institutes of Health shows that a set of proteins in the body produces a large number of mutations in human DNA, indicating that these naturally produced mutations are just as powerful as cancer-causing agents in producing tumors.
Read Article
The Promise of Immunotherapy in the Race to Cure Cancer
Value Propositions
,
Value Peer-spectives
July 2013, Vol 4, No 6
Many presentations at the 2013 annual meeting of the American Society of Clinical Oncology (ASCO) focused on new research involving immunotherapy, including drugs for melanoma and lung cancer that have shown great success in prolonging life in patients with advanced disease.
Read Article
Quality Measures Are Increasingly Tied to Physician Reimbursement
Value Propositions
,
Value Peer-spectives
July 2013, Vol 4, No 6
Quality measures and patient satisfaction are increasingly being tied to a proportion of physicians’ reimbursement, according to a new report from the Medical Group Management Association-American College of Medical Practice Executives (MGMA-ACMPE), “Physician Compensation and Production Survey: 2013 Report Based on 2012 Data.”
Read Article
Senate Bill Designates $251.9 Million for Electronic Health Records for the VA System
Value Propositions
,
Value Peer-spectives
July 2013, Vol 4, No 6
The new US Senate bill for the Veterans Affairs (VA) system provides $3.7 billion for the VA System information technology, which includes $251.9 million for an integrated electronic health record system and $119.4 million for the Veterans Benefits Management System claims systems.
Read Article
Value of Genetic Research for Drug Development: 2 Genes Identify Who Will Benefit from Breast Cancer Prophylaxis
Value Propositions
,
Value Peer-spectives
June 2013, Vol 4, No 5
>A new study supported by the National Institutes of Health Pharmacogenomics Research Network represents a step forward toward personalized medicine in breast cancer prevention among women who are at high risk for the disease.
Read Article
Disease Burden, Not Inefficiency in Care, Explains the Lion Share of Geographical Differences in Medicare Costs
Value Propositions
,
Value Peer-spectives
June 2013, Vol 4, No 5
A novel study offers a new explanation for the geographical differences seen in Medicare costs across the nation.
Read Article
Page 7 of 16
2
3
4
5
6
7
8
9
10
11
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma